✦ LIBER ✦
6007 ORAL MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukaemia but can be preferentially targeted by the MDM2 inhibitor Nutlin-3a
✍ Scribed by Tinhofer, I.; Gryshchenko, I.; Stoecher, M.; Hofbauer, S.; Daniel, P.T.; Greil, R.
- Book ID
- 123522644
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 65 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.